TITLE

Vancomycin versus Placebo for Treating Persistent Fever in Patients with Neutropenic Cancer Receiving Piperacillin-Tazobactam Monotherapy

AUTHOR(S)
Cometta, A.; Kern, W.V.; De Bock, R.; Paesmans, M.; Vandenbergh, M.; Crokaert, F.; Engelhard, D.; Marchetti, O.; Akan, H.; Skoutelis, A.; Korten, V.; Vandercam, M.; Gaya, H.; Padmos, A.; Klastersky, J.; Zinner, S.; Glauser, M.P.; Calandra, T.; Viscoli, C.
PUB. DATE
August 2003
SOURCE
Clinical Infectious Diseases;8/1/2003, Vol. 37 Issue 3, p382
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Assesses whether the addition of a glycopeptide would be able to reduce the time to defervescence in neutropenic patients with cancer. Patients' persistent fever after the initiation of empirical piperacillin-tazobactam monotherapy' Addition of amphotericin B to the therapy regimen; Lack of evidence that the addition of vancomycin therapy to the treatment regimen is of benefit to febrile neutropenic patients with cancer.
ACCESSION #
10590233

 

Related Articles

  • A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia. Wingard, John R.; White, Mary H.; Anaissie, Elias; Raffalli, John; Goodman, Jesse; Arrieta, Antonio // Clinical Infectious Diseases;11/1/2000, Vol. 31 Issue 5, p1155 

    Presents a study that compared safety of lipid formulations of amphoterecin B on the treatment of neutropenic patients. Most common invasive fungal infections in neutropenic patients; Characteristics of patients with febrile neutropenia enrolled in a comparative trial of empirical treatments;...

  • Editorial Response: Choosing Amphotericicin B Formulations--Between a Rock and a Hard Place. Bennett, John // Clinical Infectious Diseases;11/1/2000, Vol. 31 Issue 5, p1164 

    Editorial. Comments on a study concerning the use of lipid formulations of amphotericin B in treatment of febrile neutropenia. How the differences in toxicity were evaluated; Need for the hospitals to make rules about how their physicians select an amphotericin B formulations.

  • Amphotericin B Colloidal Dispersion Versus Amphotericin B in the Empirical Treatment of Fever and Neutropenia. Roland, William E.; White, Mary h. // Clinical Infectious Diseases;4/1/1999, Vol. 28 Issue 4, p935 

    Presents a comment and a response to an article about amphotericin B colloidal dispersion versus amphotericin B in the empirical treatment of fever and neutropenia. Question on the administration of normal saline bolus to patients prior to their receiving amphotericin B; Clarification on the...

  • Polymicrobial chronic endophthalmitis diagnosed by culture and molecular technique. Mukherjee, A.; Pramanik, S.; Das, D.; Roy, R.; Therese, K. L. // Indian Journal of Medical Microbiology;Jul-Sep2014, Vol. 32 Issue 3, p331 

    Accurate etiological diagnosis is the key to prevention of ocular morbidity in endophthalmitis cases. A 66 year old male was suffering from chronic endophthalmitis post-cataract surgery. Polymerase chain reaction examination on anterior chamber fluid was positive for Propionibacterium acnes but...

  • Liposomal amphotericin B poor value for febrile neutropenia.  // PharmacoEconomics & Outcomes News;6/2/2007, Issue 529, p9 

    The article research being done on liposomal amphotericin B. It references studies by C. D. Collins et al published in a 2007 issue of "Clinical Drug Investigation" and J. R. Wingard in the March 15, 2007 issue of the "American Journal of Health-System Pharmacy." The studies found that liposomal...

  • Cryptococcus neoformans Prosthetic Joint Infection: Case Report and Review of the Literature. Shah, Neel; Shoham, Shmuel; Nayak, Seema // Mycopathologia;Apr2015, Vol. 179 Issue 3/4, p275 

    A 77-year-old woman with diabetes mellitus, myasthenia gravis and bilateral total hip arthroplasties underwent a two-stage procedure followed by treatment with vancomycin for a coagulase-negative staphylococcal prosthetic hip infection. This was complicated by a spontaneous left hip dislocation...

  • Insights into Airway Infections by Enterococci: A Review. Savini, Vincenzo; Gherardi, Giovanni; Astolfi, Daniela; Polilli, Ennio; Dicuonzo, Giordano; D'Amario, Claudio; Fazii, Paolo; D'Antonio, Domenico // Recent Patents on Anti-Infective Drug Discovery;Apr2012, Vol. 7 Issue 1, p36 

    Enterococcus is an uncommon but emerging agent of upper and lower airway diseases, including sinuses, trachea, bronchi, lung and pleural infections. In particular, pneumonia and thoracic empyema may jeopardize the clinical outcome of compromised, hospitalized hosts, as well as affect...

  • Role of Infectious Diseases Consultants in Management of Antimicrobial Use in Hospitals. Sunenshine, Rebecca H.; Liedtke, Laura A.; Jernigan, Daniel B.; Strausbaugh, Larry J. // Clinical Infectious Diseases;4/1/2004, Vol. 38 Issue 7, p934 

    The Infectious Diseases Society of America Emerging Infections Network (EIN) surveyed its members to characterize antimicrobial restriction policies in their hospitals and the involvement of infectious diseases consultants in this process. Of the 502 respondents (73%), 250 (50%) indicated that...

  • Itraconazole was as effective as amphotericin B for fever and neutropenia in cancer and led to fewer adverse events. Phillips, Elizabeth J. // ACP Journal Club;Mar/Apr2002, Vol. 136 Issue 2, p58 

    Presents information on a study which investigated the effectiveness and safety of itraconazole as amphotericin B for eliminating fever and neutropenia in patients with cancer. Methodology of the study; Results; Comments on the outcome of the study.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics